Literature DB >> 20922404

Usefulness of triglyceride levels in pleural fluid.

Luis Valdés1, Maria Esther San José, Antonio Pose, Juan Carlos Estévez, Francisco J González-Barcala, José M Alvarez-Dobaño, Richard W Light.   

Abstract

The determination of pleural fluid triglycerides (PF-TRIG) is useful in the diagnosis of chylothorax, but its diagnostic value for other causes of pleural effusions is unknown. The aim of this study was to evaluate the usefulness of PF-TRIG in the diagnosis of other pleural effusions and investigate the origin of their increase in these fluids. We studied 390 pleural effusions (75 tuberculous, 107 neoplastic, 39 parapneumonic, 30 miscellaneous, 42 idiopathic, and 97 transudates). The correlation was analyzed with the PF-TRIG values as the dependent variable and serum triglycerides (S-TRIG) and the pleural fluid/serum protein ratio (PF/S PROT ratio) as independent variables. The PF-TRIG was significantly higher in exudates. The sensitivity of PF-TRIG for identifying exudates was 84.3%, specificity 61.9%. The correlation between PF-TRIG and S-TRIG was significant in the exudates and in the total pleural effusions. There was a significant correlation between PF-TRIG and S-TRIG and capillary permeability, which worsened when looking at the transudates and exudates separately. No correlations were found between the PF-TRIG and the number of red cells and white cells in any of the groups. Except for diagnosing a chylothorax, the determination of triglycerides in pleural fluid does not appear to be justified. The cause of the increase in PF-TRIG in exudates could not be established because the correlations obtained were insufficient to be able to predict PF-TRIG values from their serum values and the measurement of capillary permeability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20922404     DOI: 10.1007/s00408-010-9261-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  18 in total

Review 1.  State of the art. The pleura.

Authors:  S A Sahn
Journal:  Am Rev Respir Dis       Date:  1988-07

2.  Relationship between pleural fluid and serum cholesterol levels.

Authors:  M A Vaz; L R Teixeira; F S Vargas; A O Carmo; L Antonangelo; R Onishi; R W Light
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

3.  Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators.

Authors:  J E Heffner; L K Brown; C A Barbieri
Journal:  Chest       Date:  1997-04       Impact factor: 9.410

4.  Testing the waters. Differentiating transudates from exudates.

Authors:  V B Antony; K A Holm
Journal:  Chest       Date:  1995-11       Impact factor: 9.410

5.  The serum-effusion albumin gradient in the evaluation of pleural effusions.

Authors:  B J Roth; T F O'Meara; W H Cragun
Journal:  Chest       Date:  1990-09       Impact factor: 9.410

Review 6.  Diagnosis and treatment of tuberculous pleural effusion in 2006.

Authors:  Arun Gopi; Sethu M Madhavan; Surendra K Sharma; Steven A Sahn
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

7.  Cholesterol in pleural exudates depends mainly on increased capillary permeability.

Authors:  Luis Valdés; Esther San-José; Juan Carlos Estévez; Francisco Javier González-Barcala; José Manuel Alvarez-Dobaño; Antonio Golpe; José Manuel Valle; Pedro Penela; Luis Vizcaíno; Antonio Pose
Journal:  Transl Res       Date:  2009-12-24       Impact factor: 7.012

8.  Thoracocentesis. Clinical value, complications, technical problems, and patient experience.

Authors:  T R Collins; S A Sahn
Journal:  Chest       Date:  1987-06       Impact factor: 9.410

9.  Measurement of pleural fluid cholesterol and lactate dehydrogenase. A simple and accurate set of indicators for separating exudates from transudates.

Authors:  M Costa; T Quiroga; E Cruz
Journal:  Chest       Date:  1995-11       Impact factor: 9.410

10.  Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis.

Authors:  L Valdés; D Alvarez; E San José; J R Juanatey; A Pose; J M Valle; M Salgueiro; J R Suárez
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.